Replies

It was called Co-miRNA-Ty for a reason. It wasn't just mRNA. They have 5 untranslated regions in these vaccines. Which means it MUST change cellular genome. What until you figure out the sequence of those 5 untranslated regions.

The 50 million pulled was AZD1222 Oxford–AstraZeneca COVID-19 vaccine. They used the same processing as B.1.1.7 manufactured in Australia.

I'm trying to follow your reasoning in these two posts, but have to ask for your help to clarify.

In the first case, you reference "5 untranslated regions". I assume you're either referring to the Mrna in the "vaccine", or to the protein that it codes for. Is it one or the other, or both maybe? And what does it mean to "translate" the Mrna or protein? I think that there's general agreement that the Mrna in all of the different products codes for a modified version of the spike protein, which may be problematic in and of itself, but the question remains in my mind what specifically you are referencing.

In the second instance, you refer to the batch of australian product that was identified by the manufacturer as faulty, and withheld from the market. So far, so good. But what is the "processing (used for) the B.1.1.7 variant, formerly called "Kent variant" or Alpha? And what is the relation of the alpha variant to the AZ vaccine? Wasn't that based on the orignal Wuhan strain?

All very confusing, hope you can shed some light on this please. Thank you.